Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

NCT07116928 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

1244

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)
CKD - Chronic Kidney Disease

Interventions

DRUG: ganagliflozin
DRUG: Placebo

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.